KARUNA THERAPEUTICS

karuna-therapeutics-logo

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.

#SimilarOrganizations #People #Financial #Event #Website #More

KARUNA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2009-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.karunatx.com

Total Employee:
101+

Status:
Active

Contact:
6174823337

Email Addresses:
[email protected]

Total Funding:
1.12 B USD

Technology used in webpage:
IPv6 Cloudflare Hosting Cloudflare DNS


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Current Employees Featured

jason-brown_image

Jason Brown
Jason Brown VP of Corporate Finance @ Karuna Therapeutics
VP of Corporate Finance

andrew-c-miller_image

Andrew C. Miller
Andrew C. Miller Founder and COO @ Karuna Therapeutics
Founder and COO
2012-05-01

james-audia_image

James Audia
James Audia Head of Medicinal Chemistry @ Karuna Therapeutics
Head of Medicinal Chemistry

eric-elenko_image

Eric Elenko
Eric Elenko Director @ Karuna Therapeutics
Director

sharon-sawchak_image

Sharon Sawchak
Sharon Sawchak Clinical Development, Senior Vice President Clinical Operations @ Karuna Therapeutics
Clinical Development, Senior Vice President Clinical Operations
2022-02-01

alan-breier_image

Alan Breier
Alan Breier CMO @ Karuna Therapeutics
CMO

andrew-miller_image

Andrew Miller
Andrew Miller Founder & COO @ Karuna Therapeutics
Founder & COO
2012-05-01

mia-kelley_image

Mia Kelley
Mia Kelley Vice President of Legal Affairs @ Karuna Therapeutics
Vice President of Legal Affairs

troy-ignelzi_image

Troy Ignelzi
Troy Ignelzi Chief Financial Officer @ Karuna Therapeutics
Chief Financial Officer
2019-03-01

andrew-parratt_image

Andrew Parratt
Andrew Parratt VP of Commercial Planning & Operations @ Karuna Therapeutics
VP of Commercial Planning & Operations

Founder


andrew-miller_image

Andrew Miller

Stock Details


Company's stock symbol is NASDAQ:KRTX

Investors List

puretech-ventures_image

PureTech Health

PureTech Health investment in Series B - Karuna Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series B - Karuna Therapeutics

partner-fund-management_image

Partner Fund Management

Partner Fund Management investment in Series B - Karuna Therapeutics

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series B - Karuna Therapeutics

sands-capital-ventures_image

Sands Capital Ventures

Sands Capital Ventures investment in Series B - Karuna Therapeutics

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series B - Karuna Therapeutics

eventide-asset-management_image

Eventide

Eventide investment in Series B - Karuna Therapeutics

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series B - Karuna Therapeutics

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series B - Karuna Therapeutics

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series B - Karuna Therapeutics

Key Employee Changes

Date New article
2021-11-29 Karuna Therapeutics Appoints Charmaine Lykins as Chief Commercial Officer

Official Site Inspections

http://www.karunatx.com Semrush global rank: 2.09 M Semrush visits lastest month: 9.87 K

  • Host name: 165.89.235.72
  • IP address: 165.89.235.72
  • Location: Trenton United States
  • Latitude: 40.2187
  • Longitude: -74.7404
  • Metro Code: 504
  • Timezone: America/New_York
  • Postal: 08629

Loading ...

More informations about "Karuna Therapeutics"

Bristol Myers Squibb Strengthens Neuroscience Portfolio with ...

Dec 22, 2023 [email protected]. Source: Bristol Myers Squibb. Media downloads: 706 x 98 jpg 27 KB. Download original jpg 27 KB 706 x 98. Download thumbnail png 5 KB 200 x 28. โ€ฆSee details»

Karuna Therapeutics - Crunchbase Company Profile

Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological โ€ฆSee details»

Global Biopharmaceutical Company - Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.See details»

Karuna Therapeutics Submits New Drug Application to U.S. Food โ€ฆ

Sep 28, 2023 Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people livSee details»

Bristol Myers Squibb Strengthens and Diversifies Presence in ...

Additional Information and Where to Find it In connection with the proposed acquisition of Karuna Therapeutics by Bristol Myers Squibb, Karuna Therapeutics intends to file a preliminary and โ€ฆSee details»

Bristol Myers Squibb to Acquire Karuna Therapeutics

Additional Information and Where to Find it In connection with the proposed acquisition of Karuna Therapeutics by Bristol Myers Squibb, Karuna Therapeutics intends to file a preliminary and โ€ฆSee details»

News Release Details - PureTech Health

Nov 29, 2023 For more information, please visit www.karunatx.com. Forward-Looking Statements. This press release contains forward looking statements within the meaning of โ€ฆSee details»

Karuna Therapeutics Announces The Lancet Publication of Data โ€ฆ

BOSTON, December 14, 2023--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines โ€ฆSee details»

Karuna Therapeutics Announces U.S. Food and Drug โ€ฆ

BOSTON, November 29, 2023--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines โ€ฆSee details»

Karuna Therapeutics Reports Third Quarter 2023 Financial Results โ€ฆ

Nov 2, 2023 A webcast of the live call may be accessed on the Investor Relations page of Karunaโ€™s website at investors.karunatx.com. A replay of the webcast will be available for up to โ€ฆSee details»

Karuna Therapeutics Submits New Drug Application to U ... - Zai โ€ฆ

Sep 28, 2023 It represents the culmination of years of pre-clinical and clinical development, and a great deal of skill and hard work by our R&D organization. Our priorities over the next year โ€ฆSee details»

Karuna Therapeutics Reports First Quarter 2023 ... - Business Wire

May 4, 2023 A webcast of the live call may be accessed on the Investors section of the Karuna website at investors.karunatx.com. A replay of the webcast will be available for up to 30 days โ€ฆSee details»

PureTech Founded Entity Karuna Therapeutics to be Acquired by โ€ฆ

PureTech is a founder of Karuna and co-inventor of the KarXT program. If approved, KarXT will be the third therapeutic candidate to be taken from inception at PureTech to FDA regulatory โ€ฆSee details»

Schizophrenia - Bristol Myers Squibb

Although many people living with schizophrenia have difficulty finding an effective treatment, with the help of a dedicated care team,it is possible for people withSee details»

Karuna Therapeutics Announces U.S. Food and Drug ... - Zai Lab

May 30, 2024 For more information, please visit www.karunatx.com. Forward-Looking Statements. This press release contains forward looking statements within the meaning of โ€ฆSee details»

News Release Details - PureTech Health

Mar 20, 2023 For more information, please visit www.karunatx.com. Forward-Looking Statements. This press release contains forward looking statements within the meaning of โ€ฆSee details»

Karuna Therapeutics Announces Leadership Appointments

Aug 3, 2023 Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for peopleSee details»

Schizophrenia - Karuna

Although many people living with schizophrenia have difficulty finding an effective treatment, with the help of a dedicated care team, it is possible for people with schizophrenia to live full lives.See details»

Karuna Therapeutics Announces Positive Results from Phase 1b โ€ฆ

Nov 17, 2023 For more information, please visit www.karunatx.com. Forward Looking Statements . This press release contains forward looking statements within the meaning of โ€ฆSee details»

Karuna Therapeutics Reports Second Quarter 2022 ... - Business Wire

Aug 8, 2022 The increase in net loss for the quarter was driven by research and development expenses related to the Companyโ€™s enrollment of the Phase 3 EMERGENT and ARISE trials, โ€ฆSee details»

linkstock.net © 2022. All rights reserved